Safi Bahcall: Not long after I started the biotech firm, my father was diagnosed with a rare type of leukemia. We were a cancer-focused company and I figured I could do something to help him. Unfortunately, nothing I could do made a difference and he died not long after. Over the years, as the company grew and went public, I spent a lot of time with R&D companies of all sizes and kept noticing how promising ideas, including ones that could have helped my father, remained trapped inside these organizations’ basements. That stayed with me.